Article Information
History
- January 4, 2021.
Article Versions
- Version 1 (December 29, 2020 - 20:20).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maximilian M. Sauer1,
- M. Alexandra Tortorici1,2,
- Young-Jun Park1,
- Alexandra C. Walls1,
- Leah Homad3,
- Oliver Acton1,
- John Bowen1,
- Chunyan Wang4,
- Xiaoli Xiong1,$,
- Willem de van der Schueren5,†,
- Joel Quispe1,
- Benjamin G. Hoffstrom6,
- Berend-Jan Bosch4,
- Andrew T. McGuire3,7,8,* and
- David Veesler1,*
- 1Department of Biochemistry, University of Washington, Seattle, Washington 98195, USA
- 2Institut Pasteur, Unité de Virologie Structurale, Paris, France; CNRS UMR 3569, Unité de Virologie Structurale, Paris, France
- 3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
- 4Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
- 5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 6Antibody Technology Resource, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
- 7Department of Global Health, University of Washington, Seattle, WA 98195, USA
- 8Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA
- ↵*Correspondence: dveesler{at}uw.edu, amcguire{at}fredhutch.org